Articles

12 articles
Tag: obesity ✕
FDA Approves Eli Lilly's GLP-1 Pill Foundayo: Second Oral Obesity Drug Hits US Market Science
2026-04-06T14:05:44.662Z · Src: 2026-04-06T00:00:00.000Z
fdaelilillyglp1
Ambrosia Biosciences Raises Million Series B for Oral GLP-1 Obesity Pill Business
2026-04-04T13:46:25.530Z · Src: 2026-04-04T00:00:00.000Z
ambrosiaglp 1obesity
Ambrosia Biosciences Raises $100 Million to Challenge Oral Wegovy in the Expanding GLP-1 Pill Market Business
2026-04-04T04:50:46.136Z · Src: 2026-04-04T00:00:00.000Z
glp 1obesityambrosia
Biotech IPOs Grew Larger in Q1 2026 With Median Raise of $287.5 Million Business
2026-04-04T01:52:03.198Z · Src: 2026-04-04T00:00:00.000Z
biotechipoq12026
Ambrosia Raises $100 Million Series B for Oral GLP-1 Obesity Pill, Entering Crowded Race Business
2026-04-04T00:42:13.170Z · Src: 2026-04-04T00:00:00.000Z
ambrosiaglp1obesity
Global Medical Debate Erupts Over Proposed 'Preclinical Obesity' Diagnosis Beyond BMI Science
2026-04-03T15:17:39.343Z · Src: 2026-04-03T00:00:00.000Z
obesitybmipreclinicalobesity
Obesity Drugmaker Kailera Plans IPO After Raising $1B to Challenge Wegovy and Zepbound Business
2026-04-03T14:41:05.267Z · Src: 2026-04-03T00:00:00.000Z
kaileraipoobesity
Why Some People Can Eat Whatever They Want and Never Gain Weight Science
2026-04-02T02:12:04.667Z · Src: 2026-04-02T00:00:00.000Z
weightmetabolismgenetics
The $70 Billion GLP-1 Drug Revolution: Ozempic and Wegovy Transform Healthcare Science
2026-04-01T17:00:46.424Z · Src: 2026-04-02T00:00:00.000Z
glp 1ozempicwegovy
The Obesity Drug Revolution: GLP-1 Agonists Are Reshaping Healthcare and the Economy Science
2026-04-01T09:09:47.456Z · Src: 2026-04-01T14:00:00.000Z
glp 1ozempicwegovy
The Dark Side of Ultra-Processed Food: Why It's Being Called the New Tobacco Science
2026-04-01T08:55:21.763Z · Src: 2026-04-01T14:00:00.000Z
ultra processed foodhealthobesity
AI Digital Twins Are Helping People Manage Diabetes and Obesity Tech
2026-03-29T10:19:04.566Z · Src: 2026-03-29T00:00:00.000Z
aidigitaltwindiabetes